Vedolizumab Reduces Postoperative Crohn’s Disease Recurrence

Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in patients with at least one risk factor for recurrence.
Medscape Medical News

source https://www.medscape.com/viewarticle/vedolizumab-reduces-postoperative-crohns-disease-recurrence-2024a1000p7b?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?